Jonathan Langley Email

VP Medical Affairs . Aerovate Therapeutics

Current Roles

Employees:
50
Revenue:
$5.6M
About
Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's lead program is a potentially disease modifying drug, AV-101, for people who suffer from pulmonary arterial hypertension (PAH).
Aerovate Therapeutics Address
Boston, MA 02116, US
Boston, MA
United States
Aerovate Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.